89 related articles for article (PubMed ID: 25497707)
21. Disk diffusion method for fluconazole susceptibility testing of Candida albicans strains.
Yücesoy M; Guldaş NS; Yuluğ N
J Chemother; 2001 Apr; 13(2):161-6. PubMed ID: 11330363
[TBL] [Abstract][Full Text] [Related]
22. Synergy of the antibiotic colistin with echinocandin antifungals in Candida species.
Zeidler U; Bougnoux ME; Lupan A; Helynck O; Doyen A; Garcia Z; Sertour N; Clavaud C; Munier-Lehmann H; Saveanu C; d'Enfert C
J Antimicrob Chemother; 2013 Jun; 68(6):1285-96. PubMed ID: 23378416
[TBL] [Abstract][Full Text] [Related]
23. In vitro activities of posaconazole (Sch 56592) compared with those of itraconazole and fluconazole against 3,685 clinical isolates of Candida spp. and Cryptococcus neoformans.
Pfaller MA; Messer SA; Hollis RJ; Jones RN
Antimicrob Agents Chemother; 2001 Oct; 45(10):2862-4. PubMed ID: 11557481
[TBL] [Abstract][Full Text] [Related]
24. Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009).
Pfaller MA; Castanheira M; Messer SA; Moet GJ; Jones RN
Diagn Microbiol Infect Dis; 2011 Jan; 69(1):45-50. PubMed ID: 21146713
[TBL] [Abstract][Full Text] [Related]
25. Genotypic variation and antifungal susceptibly of Candida zeylanoides clinical isolates.
Shokri H
J Mycol Med; 2014 Sep; 24(3):179-84. PubMed ID: 24746719
[TBL] [Abstract][Full Text] [Related]
26. Influence of culture medium on susceptibility testing with BAY n 7133 and ketoconazole.
Hoeprich PD; Merry JM
J Clin Microbiol; 1986 Aug; 24(2):269-71. PubMed ID: 3528213
[TBL] [Abstract][Full Text] [Related]
27. [In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with systemic mycoses].
Uchida K; Matsuzaka A; Aoki K; Yamaguchi H
Jpn J Antibiot; 1991 May; 44(5):562-70. PubMed ID: 1652654
[TBL] [Abstract][Full Text] [Related]
28. Antifungal drug resistance in pathogenic fungi.
Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
[TBL] [Abstract][Full Text] [Related]
29. In vitro activities of voriconazole as a triazole derivative and caspofungin as an echinocandin were compared with those of some antifungal agents against Candida species isolated from clinical specimens.
Ozçelik B; Kaynak F; Cesur S; Sipahi B; Sultan N
Jpn J Infect Dis; 2007 Sep; 60(5):302-4. PubMed ID: 17881873
[TBL] [Abstract][Full Text] [Related]
30. Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro.
Martinez LR; Casadevall A
Antimicrob Agents Chemother; 2006 Mar; 50(3):1021-33. PubMed ID: 16495265
[TBL] [Abstract][Full Text] [Related]
31. Colonization of the oral cavity by yeasts in patients with chronic renal failure undergoing hemodialysis.
Godoy JS; de Souza Bonfim-Mendonça P; Nakamura SS; Yamada SS; Shinobu-Mesquita C; Pieralisi N; Fiorini A; Svidzinski TI
J Oral Pathol Med; 2013 Mar; 42(3):229-34. PubMed ID: 22978344
[TBL] [Abstract][Full Text] [Related]
32. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
[TBL] [Abstract][Full Text] [Related]
33. Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents.
Chen TC; Chen YH; Chen YC; Lu PL
Kaohsiung J Med Sci; 2012 Jun; 28(6):306-15. PubMed ID: 22632885
[TBL] [Abstract][Full Text] [Related]
34. Comparison between disk diffusion and microdilution methods for determining susceptibility of clinical fungal isolates to caspofungin.
Milici ME; Maida CM; Spreghini E; Ravazzolo B; Oliveri S; Scalise G; Barchiesi F
J Clin Microbiol; 2007 Nov; 45(11):3529-33. PubMed ID: 17728477
[TBL] [Abstract][Full Text] [Related]
35. [In vitro activities of posaconazole, fluconazole, itraconazole, ketoconazole and voriconazole against Candida glabrata].
Blanco MT; Cañadas J; García-Martos P; Marín P; García-Tapia A; Rodríguez J
Rev Esp Quimioter; 2009 Sep; 22(3):139-43. PubMed ID: 19662547
[TBL] [Abstract][Full Text] [Related]
36. [Studies on microtiter broth dilution method for antifungal susceptibility testing of yeast isolates from blood and cerebrospinal fluid].
Fujita S
Rinsho Byori; 1996 Apr; 44(4):373-8. PubMed ID: 8847821
[TBL] [Abstract][Full Text] [Related]
37. In vitro antifungal synergy between amphiphilic aminoglycoside K20 and azoles against Candida species and Cryptococcus neoformans.
Shrestha SK; Grilley M; Anderson T; Dhiman C; Oblad J; Chang CW; Sorensen KN; Takemoto JY
Med Mycol; 2015 Nov; 53(8):837-44. PubMed ID: 26260746
[TBL] [Abstract][Full Text] [Related]
38. [CHROMAgar Candida with fluconazole: comparison with microdilution techniques].
Linares MJ; Charriel G; Solís F; Casal M
Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):493-7. PubMed ID: 14572382
[TBL] [Abstract][Full Text] [Related]
39. [Onychomycosis-causing yeasts in four Mexican dermatology centers and their antifungal susceptibility to azolic compounds].
Manzano-Gayosso P; Méndez-Tovar LJ; Arenas R; Hernández-Hernández F; Millán-Chiu B; Torres-Rodríguez JM; Cortés-González E; Fernández R; López-Martínez R
Rev Iberoam Micol; 2011; 28(1):32-5. PubMed ID: 21147249
[TBL] [Abstract][Full Text] [Related]
40. Susceptibility profile of a Brazilian yeast stock collection of Candida species isolated from subjects with Candida-associated denture stomatitis with or without diabetes.
Sanitá PV; Mima EG; Pavarina AC; Jorge JH; Machado AL; Vergani CE
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Nov; 116(5):562-9. PubMed ID: 24055150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
